Pharmaceuticals This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 6.

Coventry Health Care and RxAnte Extend Relationship Focused on...
Companies will expand on initial success in improving members’ medication use and other key quality measures(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10468471.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces...
New studies show unhealthy side effects associated with the world's most popular weight loss drug. Diet Doc offers a new diet plan that provides better results than popular over-the-counter drugs,...(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/fast-weight-loss/hcg-diets/prweb10468168.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

The Veterinary Bioscience Institute Announces its Roux-en-Y Gastric...
Dr. Szczepan Baran, President of the Veterinary Bioscience Institute (http://www.vetbiotech.com), is very pleased to announce his successful gastric bypass...(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10467443.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

March 7 Atlantic Information Services Webinar Offers Guidance on...
Learn what CMS’s new proposals and implications of the 45-day notice could mean for MA plans and their partners in a March 7 webinar, sponsored by Atlantic Information Services.(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10466821.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

Under the Canopy Founder Joins the 6Pacific Team
Eco-Lifestyle Pioneer Marci Zaroff to Become Operating Partner at 6Pacific(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10466753.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

Infinata’s BioPharm Insight Releases its Catalyst Monitor for March...
Key catalysts include US approval decisions for Zogenix, Biogen Idec, and Johnson & Johnson.(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10466568.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

Global Pharmaceutical & Biotechnology Outlook 2013: India Pharma
Research and Markets announces the addition of "Global Pharmaceutical & Biotechnology Outlook 2013: India Pharma" to its catalog.(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10465761.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

Complimentary SurroundHealth Healthcare Webinar to Teach Providers...
CHES and RD credits offered for panel featuring Mount Sinai’s Malbon, UCSD’s Sadler(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10462029.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

The Veterinary Bioscience Institute Announces a Mouse Surgery Webinar...
The Veterinary Bioscience Institute announces the availability of a 2 part webinar series on Surgical Techniques in Mice. These webinars will be occurring on Wednesday February 27th and Wednesday...(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10459330.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

More Than 90% of Physicians Gain Confidence Following January Medical...
Innovaacom Workshops Help Healthcare Professionals Reduce Anxiety to Master Medical Presentations(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10454920.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

iLab Solutions Conducts Its Third Annual Core Facility Benchmarking...
Calling all research core facility managers and directors.(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10450725.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

Wohl Associates Announces the Availability of New Pre-Owned Packaging...
Wohl Associates announces additional pre-owned packaging equipment for sale.(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/used-packaging-equipment/wohl-associates/prweb10435231.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

2013 Superbones East First Podiatric Conference to be held at...
The Superbones East Podiatric Medical Conference, on April 4-6, 2013, for the first time at the Loews Miami Beach Hotel, features internationally acclaimed speakers, educational lectures and hands-on...(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/superboneseast/2013/prweb9175730.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

weMultiply Announces a Call for Health IT Innovators to Join Its...
Backed by the 9.8 Group of Companies, the newly-formed Strategic Business Accelerator focuses on technology-driven health and wellness ventures.(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/wemultiply/launch/prweb10468974.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

Rehmani Consulting, Inc. Adds Usage Statistics to Multi-User and Group...
Over 440 video tutorials on Microsoft SharePoint are available to all subscribers to SharePoint-Videos.com. Administrators for Multi-User subscriptions can now review usage statistics, by user, while...(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10468636.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

LAT Mental Health Management, Inc., Westsidetms.com and 1800GETTMS.COM...
Westside TMS is proud to partner with Neuronetics in providing a depression treatment solution and have experienced firsthand the benefits of TMS on patients.(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10467509.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

Zamansky & Associates LLC Investigates Affymax Inc. Over Its...
Zamansky & Associates LLC notifies all investors in Affymax Inc. (“Affymax”) that it is investigating the recall of Omontys, its anemia treatment for kidney dialysis patients due to reports of...(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10467316.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

Motion of Wyeth on Fen Phen Primary Pulmonary Hypertension Lawsuit...
According to court documents, on January 16th, 2013, US District Judge signed the pretrial order that the motion of Wyeth on Fen Phen primary pulmonary hypertension lawsuit is denied. In light of...(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10463936.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

Corporate Whistle Blower Center Now Urges ER Physicians To Turn In...
The Corporate Whistle Blower Center says, "We are convinced ER doctors have more insight into Medicare fraud than most people at a hospital, especially when it comes to the hospital ordering...(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10461897.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

New Stem Cell Activating Anti-aging Serums Offer Hope for Damaged Skin
Damaged and aging skin can now be repaired and rejuvenated due to new advances in stem cell and telomerase technology. A new topical agent restores skin to a youthful appearance without a visit to a...(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/rejuvenated/skin/prweb10459956.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

Taking Control of Your Diabetes (TCOYD) Will Change Lives at the Santa...
Taking Control of Your Diabetes (TCOYD) is a 501(c)3 not-for-profit organization that has been educating and motivating diabetes communities in cities around the country since 1995. TCOYD will be...(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/TCOYD/diabetesconference/prweb10339756.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

Healthcare Solutions’ Third Consecutive Year As A Finalist For Case In...
Healthcare Solutions, the parent company of Cypress Care, ScripNet and Procura Management, today announced that the company has been named as a finalist in two categories for the fourth annual Case In...(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10455608.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2013 Category: Pharmaceuticals Source Type: news

Sequestration would cost Albany hospitals $107 million
Hospitals in the Albany, NY area stand to lose about $107 million in Medicare payments under sequestration. The Budget Control Act of 2011 reduces total Medicare payments by 2 percent during the nine-year period from 2013 to 2021. These cuts, which are scheduled to take effect April 1, are in addition to the $36.5 million area hospitals will lose, over the next three years, under the Medicare deal that pulled the country back from the fiscal cliff. St. Peter’s Health Partners, the area’s largest…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 26, 2013 Category: Pharmaceuticals Authors: Barbara Pinckney Source Type: research

The Next Generation Cane -- Happy Birthday, Grandpa!
Technology elevates us all. Its helps unflinching young entrepreneurs organize burgeoning empires, it assists moms and dads navigate the ever-changing labyrinth of parenthood, it puts once unimaginable tools in the hands of builders and unattainable information at the fingerprints of students. Technology can also keep grandma and grandpa on track as they make their way home amidst a crowd of hybrid cars, spandex-ensconced roller bladers and fast-walking pedestrians texting on smartphones.
Source: Forbes.com Healthcare News - February 26, 2013 Category: Pharmaceuticals Authors: Karsten Strauss Source Type: news

Missouri Republicans file Medicaid bill
One day after voting down a Democrat-sponsored version of Medicaid expansion, a key provision of the 2010 Affordable Care Act, Missouri Republicans have filed their own version—the Show-Me State Health Transformation Act. State Rep. Jay Barnes, R-Jefferson City, who filed the Republican version of the bill on Tuesday, said his bill sets up a market-based system for managed care companies to compete on the basis of price for insuring enrollees. Here’s how it will work: Medicaid enrollees will…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 26, 2013 Category: Pharmaceuticals Authors: Samantha Liss Source Type: research

Roche launches new process for accessing clinical trial data
Roche today announced that it is expanding access to its clinical trial data for third party researchers. Roche will work with an independent body of recognised experts to evaluate and approve requests to access anonymised patient-level data. Roche will support the release of full clinical study reports (CSRs) for all its licensed medicines via regulatory authorities and make available any CSRs that cannot be provided by these authorities upon a researcher’s request.
Source: Roche Media News - February 26, 2013 Category: Pharmaceuticals Source Type: news

Four takeaways from UC's medical education speaker
University of Cincinnati’s medical school is preparing for the future of health care – but its changes are in the early stages. That was the message of Dr. Andrew Filak, senior associate dean, as he recently addressed an audience at UC’s Kresge Auditorium. Here are four takeaways from Filak’s comments: • Changes are under way. The curriculum redesign at the College of Medicine is “off to a great start,” he said. A new design for the third-year curriculum, to begin this summer, is…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 26, 2013 Category: Pharmaceuticals Authors: James Ritchie Source Type: research

Fresenius eyes €1bn profit a year early
German healthcare group expects net income should grow between 7 and 12 per cent this year despite $85m hit from US spending cuts
Source: FT.com - Drugs and Healthcare - February 26, 2013 Category: Pharmaceuticals Source Type: news

Tenet Healthcare returns to a profit in 4Q
Tenet Healthcare Corp., the Dallas-based hospital company, returned to a fourth-quarter profit with earnings of $49 million, or 45 cents per share. That compares to a loss of $76 million, or 70 cents per share, in the same quarter a year earlier. Tenet took a large charge for early retirement of debt in last year's fourth quarter, Reuters said. Tenet said that an increase in outpatient visits to its hospitals drove the rise in profit. Net operating revenue was up 7.3 percent to $2.33 billion, the…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 26, 2013 Category: Pharmaceuticals Authors: Lance Murray Source Type: research

CHOP to expand presence in King of Prussia, breaking ground this year
The Children’s Hospital of Philadelphia expects to break ground this year on a 100,000-square-foot specialty care center on North Gulph Road in King of Prussia, Pa. The hospital is still tweaking its design and budget for what will be a freestanding building on about 10 acres, said Amy Lambert, senior vice president at CHOP Care Network. CHOP bought the land from Realen Properties of Berwyn, Pa. The building will house more than 40 pediatric care specialists, the administrative offices for its…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 26, 2013 Category: Pharmaceuticals Authors: Natalie Kostelni Source Type: research

Pharma Pipeline Transparency Makes It Hard To Hide Negative Clinical Trials
Over the last decade, pharmaceutical companies began to become very transparent about their R&D productivity by periodically publishing the contents of their R&D pipelines on the company websites.02/26/2013
Source: Kidney Cancer Association - February 26, 2013 Category: Cancer & Oncology Source Type: news

OCHIN buys Oregon Health Network
Two Portland-area health information nonprofits will join forces in a move they believe will help health professionals better adapt to health reform-driven changes. OCHIN Inc., which specializes in health information technology, has acquired the Oregon Health Network for an undisclosed price. The Lake Oswego-based firm had, among other projects, worked to build Oregon's first health-focused broadband network. The group had collected more than $22 million in federal and state grants to build the…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 26, 2013 Category: Pharmaceuticals Authors: Andy Giegerich Source Type: research

Allied Healthcare authorizes repurchasing plan
Allied Healthcare Products Inc. officials have authorized the repurchase of up to 100,000 shares of the company’s common stock for a period of 90 days. Allied (NYSE: AHPI) shares closed at $2.75 a share yesterday. Company officials said the repurchase program will renew for successive 90 day periods with the company being authorized to repurchase up to 100,000 shares of common stock during each successive 90 day period. St. Louis-based Allied Healthcare Products makes respiratory products used…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 26, 2013 Category: Pharmaceuticals Authors: Matthew Hibbard Source Type: research

Government panel proposes to regulate prices of patented medicines
An Indian government panel has proposed that prices of patented medicines be based on the country's per capita income.
Source: The Economic Times Healthcare and Biotech News - February 26, 2013 Category: Pharmaceuticals Source Type: news

Many top cancer researchers are immigrants, Kauffman-funded study shows
Forty-two percent of cancer researchers at America’s top seven cancer institutes are immigrants, a new report from the National Foundation for American Policy shows. The report, financed by the Ewing Marion Kauffman Foundation, was released Monday. It analyzed biographies of about 1,500 cancer researchers at top cancer institutes. The study found that researchers from China account for 21 percent of foreign-born cancer researchers, the most of any nation. India followed with 10 percent, and Germany…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 26, 2013 Category: Pharmaceuticals Authors: Brianne Pfannenstiel Source Type: research

BSD Medical Reports Significant Growth of MicroThermX(R) Microwave Ablation System Disposable SynchroWave Antennas
SALT LAKE CITY--(Healthcare Sales & Marketing Network)--BSD Medical Corporation (BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems utilizing heat therapy to treat cancer, announced today a 319% increase in sales of its Micr... Devices, OncologyBSD Medical, MicroThermX, Microwave Ablation
Source: HSMN NewsFeed - February 26, 2013 Category: Pharmaceuticals Source Type: news

Cincinnati hospitals rank among nation's best
Two greater Cincinnati hospitals have made a national top 100 list based on overall performance. Mercy Health’s Anderson and Fairfield branches both made the Truven Health Analytics ranking released this week. They were included in the Ann Arbor, Mich.-based Truven’s “Medium Community Hospitals” category. “This is what a network of care is all about – delivering excellence across a region,” James May, CEO of Mercy Health, said in a press release. “Our hospitals do this consistently,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 26, 2013 Category: Pharmaceuticals Authors: James Ritchie Source Type: research

New Shands Jacksonville CEO on leadership, what he's reading, and why he likes living Downtown
Russell Armistead was within days of moving to Augusta, Ga., for a position with Georgia Health Sciences University when he got the call: Shands Jacksonville Medical Center CEO Jim Burkhart had resigned, and would he be willing to take the helm? Armistead was associate vice president for finance and planning for the University of Florida Health Science Center and had been working at Shands Jacksonville as a project manager when he was recruited for the Georgia position in late 2012. He had submitted…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 26, 2013 Category: Pharmaceuticals Authors: Ashley Gurbal Kritzer Source Type: research

SANUWAVE Health Announces the Appointment of CEO and Closing of its $2.0 Million Bridge Financing
ALPHARETTA, Ga., Feb. 26, 2013 -- (Healthcare Sales & Marketing Network) -- SANUWAVE Health, Inc. (SNWV) today announced that the Company has appointed Wall Street and healthcare industry veteran Joseph Chiarelli as Chief Executive Officer and a Director a... Devices, Regenerative Medicine, PersonnelSANUWAVE Health
Source: HSMN NewsFeed - February 26, 2013 Category: Pharmaceuticals Source Type: news

Holaira Bolsters Executive Team
The Company Announces Key Hires -- Steve Mertens, Kari Kubesh, Mahtab Fatemi, and Jim Pavliska MINNEAPOLIS, MN--(Healthcare Sales & Marketing Network) - Holaira, Inc., formerly Innovative Pulmonary Solutions, Inc. (IPS), a developer of medical devices... Devices, PersonnelHolaira, Innovative Pulmonary Solutions, Targeted Lung Denervation, COPD
Source: HSMN NewsFeed - February 26, 2013 Category: Pharmaceuticals Source Type: news

Vasomedical to Showcase EECP(R) Therapy and BIOX(TM) Products at American College of Cardiology's Annual Scientific Session
Exhibit Will Feature Demonstrations of the Company's Effective, Non-Invasive Treatment for Heart Disease and Diagnostic Products WESTBURY, N.Y., Feb. 26, 2013 -- (Healthcare Sales & Marketing Network) -- In continuing to spread awareness of the benefit... Devices, Cardiology, MonitoringVasomedical, Lumenair, EECP, Holter monitor
Source: HSMN NewsFeed - February 26, 2013 Category: Pharmaceuticals Source Type: news

Bausch and Lomb Names Robert Bertolini President And Chief Financial Officer
ROCHESTER, N.Y., Feb. 26, 2013 (Healthcare Sales & Marketing Network) - Bausch & Lomb, the global eye health company, has named Robert Bertolini as president and chief financial officer effective immediately. In this capacity, he will oversee the company'... Devices, Ophthalmology, PersonnelBausch & Lomb
Source: HSMN NewsFeed - February 26, 2013 Category: Pharmaceuticals Source Type: news

“Healthy Vision™ With Dr. Val Jones” Show Now Available On All About Vision®(Feb 26, 2013)
Dr. Val Jones is a paid consultant for VISTAKON® Division of Johnson & Johnson Vision Care, Inc.
Source: Johnson and Johnson - February 26, 2013 Category: Pharmaceuticals Source Type: news

Ranbaxy Surpass 2012 Guidance; Crosses Rs.120 Bn in Global Sales
Q4 CY 2012 Sales Rs.26,708 Mn CY 2012 Sales Rs.123 Bn, EBITDA Rs.18,227 Mn EBITDA margin 15%. Sales growth of 23% in Rupee terms Gurgaon, India, February 26, 2013 The Board of Directors of Ranbaxy Laboratories Limited (RLL, NSE: RANBAXY, BSE:...
Source: Drugs.com - Pharma News - February 26, 2013 Category: Pharmaceuticals Source Type: news

FDA Accepts Biologics License Application Submitted for Subcutaneous Formulation of Actemra, A Treatment for Rheumatoid Arthritis
February 26, 2013- Chugai Pharmaceutical Co., Ltd. [Head Office: Chuo-ku, Tokyo; Chairman and CEO: Osamu Nagayama (hereafter, Chugai)] and F. Hoffmann-La Roche Ltd. [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced today that the...
Source: Drugs.com - Pharma News - February 26, 2013 Category: Pharmaceuticals Source Type: news

Merck to Present at the Citi 2013 Global Healthcare Conference
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, executive vice president and chief financial officer, Merck, is scheduled to present at the Citi 2013 Global Healthcare Conference in New York on February 27 at 9:35 a.m. EST. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at http://www.merck.com/investors/events-and-presentations/home.html. ...
Source: Merck.com - Corporate News - February 26, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Financial News Source Type: news

Cubist Acquires Right to Buy Pain Treatment Maker Adynxx
BRIEF: Cubist Acquires Right to Buy Pain Treatment Maker Adynxx [Boston Herald] From Boston Herald (MA) (February 25, 2013) Feb. 25--Cubist Pharmaceuticals Inc. of Lexington said today it has the exclusive right to acquire Adynxx, a San...
Source: Drugs.com - Pharma News - February 26, 2013 Category: Pharmaceuticals Source Type: news

AstraZeneca Announces Results From Long-Term Safety Trial Of Naloxegol In Patients With Opioid-Induced Constipation
SAN FRANCISCO, Feb. 26, 2013 /PRNewswire/ -- AstraZeneca today announced high-level results from KODIAC-08, an open-label, randomised, 52-week, long-term safety trial of naloxegol versus usual care (UC) in patients with non-cancer related pain...
Source: Drugs.com - Pharma News - February 26, 2013 Category: Pharmaceuticals Source Type: news

26.02.13: Stock: Dividends
Stock: DividendsBayer proposes dividend increase to EUR 1.90 per share for 2012.Link to websiteAll changes
Source: Bayer IR Newsfeed: New on this site - February 26, 2013 Category: Pharmaceuticals Source Type: news

Bayer proposes dividend increase to EUR 1.90 per share for 2012
Payout up 15 percent to EUR 1,571 million
Source: Bayer Company News - February 26, 2013 Category: Pharmaceuticals Source Type: news